Cystic Fibrosis Pregnancy Screen Panel | Back to Test Directory | ||||
Test Description |
|
||||
Carrier screening for cystic fibrosis mutations for expectant individuals and those planning a pregnancy. Panel of 23 Cystic Fibrosis causing mutations. | |||||
Panel Components | |||||
Cystic Fibrosis Pregnancy Screen, Cystic Fibrosis Carrier Screen | |||||
Performed | Avg. Turnaround Time | Method | |||
Ankeny 24/7 |
5-10 business days | Nucleic Acid Amplification by Polymerase Chain Reaction (PCR) | |||
Fee | CPT Code(s) | ||||
$213.07 | 81220 x2 | ||||
Specimen Requirements | |||||
Specimen Type: | 4 mL Blood (preferred) or Blood spot specimen | ||||
Collection Instructions: |
Blood specimen (preferred): Collect 4 mL blood in lavender top tube (EDTA) from BOTH male and female reproductive partners. |
||||
Temperature and Stability: | Blood specimen: Transport at room temperature; refrigerate when storing. Blood spot specimen: Room Temperature. | ||||
Unacceptable Conditions: | Blood specimen: Heparin anticoagulant. Blood spot specimen: Blood exhibiting layering, clotting, insufficient quantity, dilution, contamination, serum separation, or didn't soak through the filter paper. For questions call the Newborn Screening Laboratory at 515/725-1630. | ||||
Expected Results: | Pregnancy Initial Risk, Final Risk, and Result (Negative, At Risk). Mother's Initial Risk, Final Risk, and Result as a carrier. Partner's Initial Risk, Final Risk, and Result as a carrier. | ||||
Shipping Instructions | |||||
Blood specimen: Wrap specimen in absorbent material and place inside a biohazard bag along with a completed Cystic Fibrosis Test Request Form. Blood spot specimen: Place dry blood spot specimen and a completed Cystic Fibrosis Test Request Form in an envelope. Transport specimen at room temperature. Send to: Iowa Newborn Screening Program, State Hygienic Laboratory, 2220 S. Ankeny Blvd., Ankeny, IA 50023-9093. | |||||
Comments | |||||
Iowa Cystic Fibrosis Pregnancy Screening requires a completed order and a specimen from BOTH male and female reproductive partners. Submissions not meeting this requirement will be rejected. A negative screen result does not exclude the possibility of a CF mutation not included in this 23 mutation test panel. |